April 15, 2025 By Syafiq Kusni Over the course of the last decade, my optometry training has taken me from Singapore to...
BHVI’s Myopia Calculator is the first online toolkit designed to help eye care practitioners effectively communicate projected myopia progression and treatment efficacy...
April 2, 2025 DEL MAR, Calif. — Sydnexis has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human...
April 1, 2025 By Aamena Kazmi, OD, ABO Diplomate As myopia prevalence increases globally, collaborative relationships with ophthalmologists and optometrists is essential...
March 17, 2025 By Michael Lipson, OD, and Bruce Koffler, MD The following is the second of two articles on the assessment...
March 11, 2025 DEL MAR, Calif. — The U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for...
March 3, 2025 By Dwight Barnes, OD, FIAOMC, IACMM Myopia management has grown substantially in recent years, from a relatively uncommon treatment...
March 3, 2025 By Associate Professor Pauline Kang, BOptom, PhD, School of Optometry and Vision Science at UNSW in Sydney, Australia As...
February 18, 2025 By Dwight Akerman, OD, MBA, FAAO, Dipl AAO, FBCLA, FIACLE Yum et al. investigated the synergistic effect of dual-focus...
February 3, 2025 By Erica Barclay, OD The International Myopia Institute has defined pre-myopia as “a refractive state of an eye of...
February 3, 2025 By Dwight Akerman, OD, MBA, FAAO, Dipl AAO, FBCLA, FIACLE The study “Efficacy and Safety of Different Atropine Regimens...
February 3, 2025 By Eman Alzghoul, PhD, FIACLE, FBCLA Adult myopia progression is commonly observed in clinical practice, yet there is a...
Myopia is increasingly prevalent worldwide, posing significant risks to eye health, particularly as it progresses into high myopia. The rise in...
January 2, 2025 By Leila Sara Eppenberger, MD, FEBO, FMH, MSc ETH Over the past few decades, the options for controlling myopia...
sponsored content December 16, 2024 Privately held, clinical-stage pharmaceutical company, Sydnexis Inc. has recently completed an evaluation of its patented low-dose atropine...
December 9, 2024 MARKHAM, Ontario, Canada – On Sunday, December 8, leaders in the eye care field gathered here for THE Myopia...
November 15, 2024 NEW YORK, NY — Eyenovia has shared that its Phase 3 CHAPERONE study is currently not meeting its primary...
November 15, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In the article “Putting efficacy into context: do controlled trials on...
November 15, 2024 By Joseph Munsell, OD I was first introduced to myopia management in optometry school at Pacific University, though it...
November 1, 2024 By Tina Douroudian, OD Children need our best available treatment options now — allowing their myopia to progress while...
November 1, 2024 By James S. Wolffsohn BSc, MBA, PhD, Professor and Dean of the School of Optometry, Aston University There is...
November 1, 2024 Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In their review article, “Efficacy in myopia control — The impact of...
October 15, 2024 By Alyssa Pack, OD In a family of several optometrists and a myope myself, my experience with myopia management...
October 1, 2024 By Diba Rezazadeh, OD, AdvCertChVis(ACO) Topical low-dose atropine has become a popular myopia control treatment, and its ability to...
October 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The retrospective study conducted by Wen et al. (2024) aimed to...
October 1, 2024 By David Anderson, OD, and Taylor Sprague, OD, FAAO One major challenge with presenting myopia management to patients and...
September 16, 2024 By Y. Shira Kresch, OD, MS, FAAO We want our patients to be educated about the risks of untreated...